
NYSE:JPM
Flagship US bank. Dimon has done a spectacular job. Pristine risk controls. Trading ~13x PE. Either #1 or #2 in all of its major businesses. Still growing and gaining market share. Core holding in any portfolio. Time is ripe to buy the best, you don't have to go down the food chain. Yield is 2.73%.
(Analysts’ price target is $266.16)Likes them both, as well as others in the sector. Don't look at the chart and not buy because it's gone up so much and you've "missed" the price move. Instead, look at the fundamentals -- have earnings, cashflow, revenue growth kept up with the price? Or, look to how it's trading against historical valuations.
This one is up against the upper end of its historical valuation, trading at about 2x book. Somewhat extended, but a great franchise. Good economy, reduced regulation. Unlike other areas of the market, valuations in financials are not extended, so there's opportunity.
Huge move up on Trump bump. Yield curve's in better shape than it's been for a long time. Net interest margins are better. The space will see lots more M&A. Will go higher if the space does. Trades at 13x for only 7% growth, not a good deal for a bank. He'd look at Citi instead.
Highest quality, Jamie Dimon, gold standard. Don't buy at these prices.
This week, they reported a terrific quarter: a huge sales and earnings beat with all 3 business units performing better than expected, especially the business and investment side. This saw 18% revenue growth, driven by a 49% increase in investment banking fees. Spending came in lower than expected, and they raised their 2025 net interest forecast while maintaining its expense guidance. Their CEO sees more growth in business, overall.
Financial sector offers great promise, though it's reacted to current markets by pricing in a potential recession. Slower economic growth would not be good for banks. Absent a recession, with consumer confidence returning and unleashing M&A, the sector provides a good opportunity.
Don't value it on PE. Instead look at price to book, and it's expensive at 1.8x. Less expensive options include BAC and C.